| 33.01 Data as of May 21 |  -0.05 / -0.15%Today’s Change | 22.02 Today|||52-Week Range 34.70 | +21.14% Year-to-Date |
| QIAGEN Downgraded to Strong Sell - Analyst Blog May 21 / Zacks.com | Covidien Prices Senior Notes - Analyst Blog May 16 / Zacks.com |
| FDA Nod for COV's Advanced Nellcor - Analyst Blog May 21 / Zacks.com | Much Awaited Test Launch by Genomic - Analyst Blog May 15 / Zacks.com |
| CE Mark for STJ's ILUMIEN OPTIS - Analyst Blog May 17 / Zacks.com | Myriad Soars Higher on Celeb Clout - Analyst Blog May 15 / Zacks.com |
| Stryker Reiterated at Neutral - Analyst Blog May 17 / Zacks.com | Stocks to Watch: Cisco, BlackBerry, Macy's May 15 / TheStreet.com |
| SGEN's Adcetris under FDA Review - Analyst Blog May 16 / Zacks.com | Jolie's mastectomy highlights genetic testing company May 14 / CNNMoney.com |
| Previous close | 33.06 |
| Today’s open | 33.20 |
| Day’s range | 33.00 - 33.49 |
| Volume | 892,015 |
| Average volume (3 months) | 1,166,978 |
| Market cap | $2.6B |
| Dividend yield | -- |
| Earnings growth (last year) | +18.18% |
| Earnings growth (this year) | +27.91% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | +23.36% |
| P/E ratio | 20.9 |
| Price/Sales | 4.05 |
| Price/Book | 4.29 |
| Today’s change | Today’s % change | |
|---|---|---|
| TAROTaro Pharmaceutical ... | +0.24 | +0.38% |
| OPKOPKO Health Inc | -0.06 | -0.86% |
| QCORQuestcor Pharmaceuti... | -0.40 | -1.06% |
| INCYIncyte Corp | -0.89 | -3.84% |
| Next reporting date | August 20, 2013 |
| EPS forecast (this quarter) | $0.43 |
| Annual revenue (last year) | $496.0M |
| Annual profit (last year) | $112.2M |
| Net profit margin | 22.61% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Peter D. Meldrum |
Executive Vice President- International Operations Gary A. King, MBA |
Corporate headquarters Salt Lake City, Utah |
.
